IL136138A0 - Arylthiazolidinedione derivatives - Google Patents
Arylthiazolidinedione derivativesInfo
- Publication number
- IL136138A0 IL136138A0 IL13613898A IL13613898A IL136138A0 IL 136138 A0 IL136138 A0 IL 136138A0 IL 13613898 A IL13613898 A IL 13613898A IL 13613898 A IL13613898 A IL 13613898A IL 136138 A0 IL136138 A0 IL 136138A0
- Authority
- IL
- Israel
- Prior art keywords
- ppar
- arylthiazolidinedione
- derivatives
- arylthiazolidinedione derivatives
- thiazolidinediones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6827197P | 1997-12-19 | 1997-12-19 | |
| GBGB9816279.5A GB9816279D0 (en) | 1998-07-27 | 1998-07-27 | Arylthiazolidinedione derivatives |
| US10523898P | 1998-10-22 | 1998-10-22 | |
| PCT/US1998/027139 WO1999032465A1 (fr) | 1997-12-19 | 1998-12-18 | Derives d'arylthiazolidinedione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136138A0 true IL136138A0 (en) | 2001-05-20 |
Family
ID=27269416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13613898A IL136138A0 (en) | 1997-12-19 | 1998-12-18 | Arylthiazolidinedione derivatives |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1040102B1 (fr) |
| JP (1) | JP3373198B2 (fr) |
| KR (1) | KR20010033355A (fr) |
| CN (1) | CN1282325A (fr) |
| AT (1) | ATE352545T1 (fr) |
| AU (1) | AU740733B2 (fr) |
| BG (1) | BG104602A (fr) |
| BR (1) | BR9813801A (fr) |
| CA (1) | CA2315397C (fr) |
| DE (1) | DE69836980T2 (fr) |
| EA (1) | EA200000687A1 (fr) |
| ES (1) | ES2281146T3 (fr) |
| HU (1) | HUP0101366A2 (fr) |
| ID (1) | ID24878A (fr) |
| IL (1) | IL136138A0 (fr) |
| IS (1) | IS5506A (fr) |
| NO (1) | NO20003112L (fr) |
| PL (1) | PL340958A1 (fr) |
| SK (1) | SK9212000A3 (fr) |
| TR (1) | TR200001753T2 (fr) |
| WO (1) | WO1999032465A1 (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9824614D0 (en) * | 1998-11-11 | 1999-01-06 | Glaxo Group Ltd | Chemical compounds |
| EP1053989B1 (fr) * | 1999-05-20 | 2007-07-25 | Ciba SC Holding AG | Composés hydroxyles d'éther diphénylique |
| WO2000078312A1 (fr) * | 1999-06-18 | 2000-12-28 | Merck & Co., Inc. | Derives d'arylthiazolidinedione et d'aryloxazolidinedione |
| WO2000078314A1 (fr) * | 1999-06-18 | 2000-12-28 | Merck & Co., Inc. | Procede de preparation de derives d'arylthiazolidinedione |
| AU7073400A (en) | 1999-08-27 | 2001-03-26 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| PL356745A1 (en) * | 1999-11-10 | 2004-06-28 | Takeda Chemical Industries, Ltd | Body weight gain inhibitors |
| AU2001298065A1 (en) * | 2001-01-12 | 2003-09-02 | Abbott Laboratories | Process for the preparation of matrix metalloproteinase inhibitors |
| DE60237594D1 (de) * | 2001-04-25 | 2010-10-21 | Takeda Pharmaceutical | Verwendung des abc-expressionspromotors pioglitazon zur behandlung von arteriosklerose obliterans |
| EP1534696A4 (fr) * | 2002-07-25 | 2010-04-07 | Merck Sharp & Dohme | Composes therapeutiques destines au traitement d'etats dyslipidemiques |
| MXPA05005583A (es) * | 2002-11-26 | 2005-07-27 | Pfizer Prod Inc | Activadores de ppar. |
| CN1319956C (zh) * | 2003-09-12 | 2007-06-06 | 深圳市海粤门生物科技开发有限公司 | 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用 |
| PL2243766T3 (pl) * | 2003-09-19 | 2016-02-29 | Janssen Pharmaceutica Nv | Kwasy 4-((fenoksyalkilo)tio)-fenoksy octowe do zastosowania w leczeniu stanów, w których pośredniczy PPAR-delta |
| BRPI0414268B8 (pt) * | 2003-09-19 | 2021-05-25 | Janssen Pharmaceutica Nv | ácidos 4-((fenoxialquil)tio)-fenoxiacéticos, análogos, e composições farmacêuticas |
| RU2355682C2 (ru) * | 2004-01-20 | 2009-05-20 | Мерк Энд Ко., Инк. | Антидиабетические оксазолидиндионы |
| WO2006138328A1 (fr) * | 2005-06-14 | 2006-12-28 | Merck & Co., Inc. | Procede de production d'oxazolidinediones anti-diabetiques |
| JP2009500355A (ja) | 2005-07-06 | 2009-01-08 | メルク エンド カムパニー インコーポレーテッド | 抗糖尿病性オキサゾリジンジオン及びチアゾリジンジオン |
| JP2009502783A (ja) * | 2005-07-20 | 2009-01-29 | メルク エンド カムパニー インコーポレーテッド | 抗糖尿病性オキサゾリジンジオン及びチアゾリジンジオン |
| MX2009013332A (es) | 2007-06-08 | 2010-01-25 | Mannkind Corp | Inhibidores de ire-1 alfa. |
| CN105001174A (zh) * | 2015-07-14 | 2015-10-28 | 佛山市赛维斯医药科技有限公司 | 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途 |
| CN104987314A (zh) * | 2015-07-14 | 2015-10-21 | 佛山市赛维斯医药科技有限公司 | 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3053490B2 (ja) * | 1991-02-25 | 2000-06-19 | 杏林製薬株式会社 | チアゾリジン−２，４−ジオン誘導体とその塩及び製造法 |
| JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| ES2202582T3 (es) * | 1996-02-02 | 2004-04-01 | MERCK & CO., INC. | Agentes antidiabeticos. |
| CA2245524A1 (fr) * | 1996-02-02 | 1997-08-07 | Wei Han | Agents antidiabetiques |
| DE69720429T9 (de) * | 1996-02-02 | 2004-09-23 | Merck & Co., Inc. | Heterocyclische verbindungen als antidiabetische mittel und für die behandlung von fettleibigkeit |
| US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
-
1998
- 1998-12-18 JP JP2000525402A patent/JP3373198B2/ja not_active Expired - Fee Related
- 1998-12-18 ID IDW20001163A patent/ID24878A/id unknown
- 1998-12-18 HU HU0101366A patent/HUP0101366A2/hu unknown
- 1998-12-18 AU AU18334/99A patent/AU740733B2/en not_active Ceased
- 1998-12-18 CA CA002315397A patent/CA2315397C/fr not_active Expired - Fee Related
- 1998-12-18 TR TR2000/01753T patent/TR200001753T2/xx unknown
- 1998-12-18 PL PL98340958A patent/PL340958A1/xx not_active Application Discontinuation
- 1998-12-18 AT AT98963283T patent/ATE352545T1/de not_active IP Right Cessation
- 1998-12-18 EA EA200000687A patent/EA200000687A1/ru unknown
- 1998-12-18 SK SK921-2000A patent/SK9212000A3/sk unknown
- 1998-12-18 DE DE69836980T patent/DE69836980T2/de not_active Expired - Fee Related
- 1998-12-18 BR BR9813801-4A patent/BR9813801A/pt not_active Application Discontinuation
- 1998-12-18 CN CN98812229A patent/CN1282325A/zh active Pending
- 1998-12-18 KR KR1020007006820A patent/KR20010033355A/ko not_active Application Discontinuation
- 1998-12-18 WO PCT/US1998/027139 patent/WO1999032465A1/fr active IP Right Grant
- 1998-12-18 EP EP98963283A patent/EP1040102B1/fr not_active Expired - Lifetime
- 1998-12-18 IL IL13613898A patent/IL136138A0/xx unknown
- 1998-12-18 ES ES98963283T patent/ES2281146T3/es not_active Expired - Lifetime
-
2000
- 2000-05-23 IS IS5506A patent/IS5506A/is unknown
- 2000-06-16 NO NO20003112A patent/NO20003112L/no not_active Application Discontinuation
- 2000-07-13 BG BG104602A patent/BG104602A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU1833499A (en) | 1999-07-12 |
| HUP0101366A2 (hu) | 2001-09-28 |
| PL340958A1 (en) | 2001-03-12 |
| DE69836980T2 (de) | 2007-11-15 |
| JP2001526278A (ja) | 2001-12-18 |
| EA200000687A1 (ru) | 2000-12-25 |
| JP3373198B2 (ja) | 2003-02-04 |
| NO20003112L (no) | 2000-08-18 |
| SK9212000A3 (en) | 2001-02-12 |
| ATE352545T1 (de) | 2007-02-15 |
| CN1282325A (zh) | 2001-01-31 |
| AU740733B2 (en) | 2001-11-15 |
| ID24878A (id) | 2000-08-31 |
| EP1040102B1 (fr) | 2007-01-24 |
| IS5506A (is) | 2000-05-23 |
| ES2281146T3 (es) | 2007-09-16 |
| BR9813801A (pt) | 2000-10-03 |
| EP1040102A1 (fr) | 2000-10-04 |
| WO1999032465A1 (fr) | 1999-07-01 |
| TR200001753T2 (tr) | 2000-11-21 |
| DE69836980D1 (de) | 2007-03-15 |
| CA2315397C (fr) | 2007-08-07 |
| EP1040102A4 (fr) | 2002-11-27 |
| NO20003112D0 (no) | 2000-06-16 |
| BG104602A (bg) | 2001-01-31 |
| KR20010033355A (ko) | 2001-04-25 |
| CA2315397A1 (fr) | 1999-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1194146A4 (fr) | Derives d'arylthiazolidinedione et d'aryloxazolidinedione | |
| IL136138A0 (en) | Arylthiazolidinedione derivatives | |
| AU7705601A (en) | N-substituted indoles useful in the treatment of diabetes | |
| WO2002026729A3 (fr) | Derives d'acide benzopyrancarboxylique utilises pour le traitement du diabete et des troubles lipidiques | |
| WO2002064094A3 (fr) | Acides 2-aryloxy-2-arylalcanoïques utilisés pour le traitement du diabètes et des troubles lipidiques | |
| WO2002060388A3 (fr) | Acyl-sulfamides pour le traitement de l'obesite, du diabete et des troubles lipidiques | |
| NO20015607D0 (no) | Glukagonantagonister/inversagonister | |
| AU549102B2 (en) | Aromatic heterocyclic esters of steroids | |
| AP9700918A0 (en) | Benzoxazoles and pyridine derivatives useful in the treatment of the type II diabetes | |
| HUP0003876A3 (en) | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes | |
| AU7678096A (en) | Therapeutic medical garments for scars and process | |
| AU5537994A (en) | Therapeutic treatment for inhibiting vascular restenosis | |
| PL338126A1 (en) | Treatment of diabetes by means of derivatives of thiazolydinone, of insulin secretion stimulating agent and of biguanidinic derivative | |
| AU6212398A (en) | 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia | |
| AU7484596A (en) | Combination therapy for the treatment of diabetes and obesity | |
| AU7595298A (en) | Azolidinediones useful for the treatment of diabetes, dyslipidemia and hy pertension | |
| AU7387491A (en) | Benzoxazine derivatives, process for their preparation and thier use for the treatment or for the prophylaxis of diseases | |
| ECSP993022A (es) | Derivados de ariltiazolidindiona | |
| DE69526731D1 (en) | Hypocholesterolämische,antiatherosklerotische und hypotriglyceridämische mercaptoacetylamid-derivate | |
| AU8069891A (en) | Novel alpha-glucosidase inhibitors | |
| AU1097892A (en) | Process and installation for the treatment of steel-mill slag | |
| AR018898A1 (es) | Derivados de 5-aril-2,4-tiazolidindiona, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de un medicamento | |
| IE900460L (en) | Pharmaceutical composition | |
| AU9797598A (en) | Treatment of diabetic retinopathy | |
| AU8411991A (en) | Treatment of asbestos or like material |